B

우리바이오

082850KOSDAQ

55.5 / 100

Reference Date: 2026-10-23

Financial Score20.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 7.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Ourbio operates five business segments, including health functional foods, FPCB and electronic components, LED modules, real estate, and nanofiber fabrics. It is actively expanding its health functional food market through brands like 'Solutio' and 'Harutin,' while the FPCB segment benefits from growing demand in smart devices and automotive industries. The company is also expanding into bio-related fields, such as medical cannabis research.

Number of Employees

95people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.16Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-3.84Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
18.87Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.9% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼67.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 2.4% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (69%)

Current 4,335Won52-week high 5,83052-week low 859
1-month return1.0Point

1m -7.17% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0